Sepulveda-Falla, Diego http://orcid.org/0000-0003-0176-2042
Sanchez, Justin S.
Almeida, Maria Camila
Boassa, Daniela
Acosta-Uribe, Juliana
Vila-Castelar, Clara
Ramirez-Gomez, Liliana
Baena, Ana
Aguillon, David
Villalba-Moreno, Nelson David
Littau, Jessica Lisa
Villegas, Andres
Beach, Thomas G.
White, Charles L. III
Ellisman, Mark
Krasemann, Susanne
Glatzel, Markus
Johnson, Keith A.
Sperling, Reisa A.
Reiman, Eric M.
Arboleda-Velasquez, Joseph F.
Kosik, Kenneth S.
Lopera, Francisco
Quiroz, Yakeel T.
Funding for this research was provided by:
National Institute of Aging (R01 AG054671)
Massachusetts General Hospital Executive Committee on Research
Alzheimer’s Association Research Grant
Deutsche Forschungsgemeinschaft (CellNetFAD # 458854216)
National Institute of Neurological Disorders and Stroke (RF1 NS110048, RF1 NS110048, UH3 NS100121)
Alzheimer’s Association Research Fellowship
Universidad de Antioquia
Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/22819-8)
Werner Otto Stiftung
Bundesministerium für Bildung und Forschung (UndoAD)
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 29 March 2022
Revised: 21 June 2022
Accepted: 1 July 2022
First Online: 15 July 2022
Declarations
:
: RAS has received personal compensation from AC Immune, Eisai, Roche, and Takeda, and research grant support from Eli Lilly and Janssen. YTQ, JFAV, EMR, FL are listed as co-inventors of a patent application for therapeutics modulating interactions between APOE and HSPG filed by MGB. All other authors have no competing interests.